ALXO — ALX Oncology Holdings Balance Sheet
0.000.00%
Last trade - 00:00
- $782.37m
- $611.58m
- 44
- 13
- 93
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 9.02 | 434 | 364 | 266 | 183 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.536 | 0 | — | — | 1 |
Prepaid Expenses | |||||
Total Current Assets | 9.81 | 436 | 367 | 271 | 189 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.86 | 0.052 | 3.4 | 9.79 | 10.8 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 10.7 | 436 | 380 | 306 | 243 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.98 | 6.2 | 15.3 | 28.3 | 36 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 11 | 6.21 | 17.1 | 43 | 52.8 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.276 | 430 | 363 | 263 | 190 |
Total Liabilities & Shareholders' Equity | 10.7 | 436 | 380 | 306 | 243 |
Total Common Shares Outstanding |